Oncolytics Biotech Inc T.ONC

ONC fair value is $152.36 CDN or $114USD

[TMAZZ21]

According to this website to the below website ONC fair value is $152.36 CDN

Now ponder that stock price 

https://simplywall.st/stocks/ca/pharmaceuticals-biotech/tsx-onc/oncolytics-biotech-shares/valuation


 

Share Price vs Fair Value

What is the Fair Price of ONC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

 

DataLearn

 

Below Fair Value: ONC (CA$2.49) is trading below our estimate of fair value (CA$152.36)

[Buckhenry]

yes but you did not read the fine print.... that was in monopoly money!!! lol

[canadafan]

Onc traded at $60+/ share years ago, when it was discovered that Pelareorep only lives in cancer cells. brining up to todays standards. RBC uses present value calculations of forward sales, based on an estimated market of $5billion/ year in sales. That only includes MBc cancer treatment.  They do add significant upside with additional data. a sp of $150 would indicate a market cap of

[Noteable]

Sounds about right.

[Noteable]

The above valuation estimates revenues of approximately US$7.75 per share = US$155 per share at 20 price to earnings (p/e) = US$9.45 Billion as a "fair value" valuation for ONCY.

[Noteable]

For comparison Merck announced full year 2022 worldwide sales at $59.3 billion, an increase of 22% from full year 2021. During 2022, Keytruda sales climbed to $20.94 billion, up 22 percent from $17.19 billion in 2021. Lynparza sales were also up for the full year, hitting and exceeding the billion-dollar sales mark for the first time at $1.12 billion, a 13 percent increase versus $989

[Noteable]

Here's what the Doctor said : "Considering that ONCY has the potential of increasing the effectiveness of PD-(L)1 inhibitors by 2-3x, Big Pharma companies that currently possess an immune checkpoint inhibitor appear significantly interested in acquiring ONCY (pelareorep) given pelareorep's ability to enhance checkpoint inhibitor efficacy while expanding the PD-(L)1 market in the

[Noteable]

With the potential of ONCY's forward earnings equalling US$7.75 per share x 20 p/e = US$155 per share = US$9.45 Billion as a "fair value" valuation for ONCY. Notwithstanding that the historical P/E for the biotechnology sector is considerable higher (between 20 and 48) as referenced below: https://eqvista.com/price-to-earnings-pe-ratios-by-industry/ Biotechnology

[Lesalpes29]

Not many People are betting on the potential! But who knows, maybe I'm sitting on a pile of cash! 

[Noteable]

Lesalpes29 : You and your friends appear to be the only "Not many People" that you have referenced. And I won't comment on the way that you are "betting".

[Buckhenry]

Lesaples... I would not expect a Christmas card from unnoteable this year.  I honestly cant believe how polarized folks get on this site. this just folks opinions and speculation.  I treat  this as an entertainment site and maybe glean a bit of pertinent information now and then.  otherwise its just fun to irritate the dreaming forever pumpers. 

[YegJeeber]

And what makes YOU any different by deriding those show support or make "pumping" comments about ONCY? Hypocrite - they name is basher. 

[Buckhenry]

unnoteable and some others have just got out of hand here. they can't tolerate anyone who thinks different or has a different viewpoint. and know there is dissension among their clan. no one knows if there is a buyout on the horizon and they certainly dont know the price so quit showing your ignorance.